Name | Title | Contact Details |
---|
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Cartessa Aesthetics is a progressive company focused on sourcing, distributing, and supporting class-leading technology to plastic surgeons, dermatologists, physicians and medical spas.
Optogenics Of Syracuse Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Civatech Oncology Inc. is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Digital Transcription System is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.